Full text is available at the source.
Patient and physician factors driving the gaps in use of drugs with cardiovascular and kidney benefits by medicare beneficiaries with type 2 diabetes treated by endocrinologists, nephrologists, and cardiologists: Population-based cohort study
Patient and doctor factors linked to gaps in use of heart and kidney protective drugs in Medicare patients with type 2 diabetes treated by diabetes, kidney, and heart specialists
AI simplified
Abstract
41.9% of patients treated by endocrinologists filled prescriptions for GLP-1 receptor agonists or SGLT2 inhibitors.
- 73.2% of patients treated by endocrinologists filled diabetes medications prescribed by their specialists.
- Only 9.8% of patients treated by nephrologists and 6.1% by cardiologists filled diabetes medications.
- Among those who filled any diabetes medication, 59.5% of nephrologist-treated and 48.2% of cardiologist-treated patients filled a GLP-1RA or SGLT2i.
- Older patients of endocrinologists and nephrologists were less likely to fill prescriptions for GLP-1RA/SGLT2i.
- Patients treated by older nephrologists and cardiologists were also less likely to fill these prescriptions.
AI simplified